SANANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Sana Biotechnology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$2.30+0.03 (+1.32%)
Close on Oct 19, 2026
- Market cap
- $680.03M
- P/E (TTM)
- –
- Dividend yield
- –
Sana Biotechnology statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Market Cap | $688.53M | $166.30M |
| Enterprise Value | $528.04M | $88.19M |
| PB Ratio | 4.45 | 2.03 |
Income (trailing twelve months)
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Operating Income | -$218.75M | -$21.40M |
| Net Income | -$211.82M | -$22.46M |
| EBITDA | -$218.75M | -$16.91M |
| EPS (Diluted) | -$0.76 | -$0.83 |
Returns
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Return on Equity (ROE) | -152.9% | -53.2% |
| Return on Assets (ROA) | -53.4% | -40.9% |
| Return on Invested Capital (ROIC) | -869.2% | -32.4% |
| Return on Capital Employed (ROCE) | -71.1% | -38.1% |
Balance sheet
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $160.49M | $61.43M |
| Net Cash (Debt) | $160.49M | $15.35M |
| Net Cash Per Share | $0.54 | $0.66 |
| Equity (Book Value) | $154.57M | $49.09M |
| Book Value Per Share | $0.52 | $1.37 |
| Tangible Book Value | -$45.25M | $23.52M |
| Working Capital | $46.88M | $76.81M |
Financial position
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Current Ratio | 1.38 | 3.34 |
| Quick Ratio | 1.30 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Operating Cash Flow | -$132.24M | -$12.35M |
| Capital Expenditures | -$2.82M | -$1.08M |
| Free Cash Flow | -$135.06M | -$20.22M |
| FCF Per Share | -$0.45 | -$0.42 |
Efficiency
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Profits Per Employee | -$1.49M | -$703.34K |
| Employee Count | 142 | 74 |
Dividends and yields
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Earnings Yield | -30.8% | -23.3% |
| FCF Yield | -19.6% | -8.72% |
Shares
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Shares Outstanding | 299,361,000 | 58,127,000 |
| Shares Change (YoY) | 17.0% | 10.9% |
| Shares Change (QoQ) | 10.9% | 0.54% |
| Float | 230,296,000 | 49,136,700 |
| Shares Held by Insiders | 23.1% | 11.6% |
| Shares Held by Institutions | 61.7% | 59.4% |
Scores
| Measure | Sana Biotechnology | Industry median |
|---|---|---|
| Altman Z-Score | -6.41 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Sana Biotechnology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.